
Jon E. Angell
Examiner (ID: 6922)
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1637, 1674, 1635 |
| Total Applications | 1428 |
| Issued Applications | 719 |
| Pending Applications | 199 |
| Abandoned Applications | 530 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11290747
[patent_doc_number] => 20160340680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'MODULATION OF KCNH2 ISOFORM EXPRESSION BY OLIGONUCLEOTIDES AS A THERAPEUTIC APPROACH FOR LONG QT SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 15/230718
[patent_app_country] => US
[patent_app_date] => 2016-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9829
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15230718
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/230718 | Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic approach for long QT syndrome | Aug 7, 2016 | Issued |
Array
(
[id] => 13234935
[patent_doc_number] => 10130651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => RNAi Therapy for Hepatitis B Virus Infection
[patent_app_type] => utility
[patent_app_number] => 15/229314
[patent_app_country] => US
[patent_app_date] => 2016-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27009
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15229314
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/229314 | RNAi Therapy for Hepatitis B Virus Infection | Aug 4, 2016 | Issued |
Array
(
[id] => 11929994
[patent_doc_number] => 09796979
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Oligonucleotide modulators of the toll-like receptor pathway'
[patent_app_type] => utility
[patent_app_number] => 15/222695
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 48485
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15222695
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/222695 | Oligonucleotide modulators of the toll-like receptor pathway | Jul 27, 2016 | Issued |
Array
(
[id] => 13329153
[patent_doc_number] => 20180216114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => XANTHINE DEHYDROGENASE (XDH) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/747571
[patent_app_country] => US
[patent_app_date] => 2016-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -98
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747571 | XANTHINE DEHYDROGENASE (XDH) IRNA COMPOSITIONS AND METHODS OF USE THEREOF | Jul 25, 2016 | Abandoned |
Array
(
[id] => 13343595
[patent_doc_number] => 20180223337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => METHODS FOR DETECTING AND TREATING LOW-VIRULENCE INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 15/746666
[patent_app_country] => US
[patent_app_date] => 2016-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -91
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15746666
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/746666 | METHODS FOR DETECTING AND TREATING LOW-VIRULENCE INFECTIONS | Jul 20, 2016 | Abandoned |
Array
(
[id] => 13508423
[patent_doc_number] => 20180305754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => BIOMARKER FOR DIAGNOSIS OF DRUG ADDICTION AND KIT FOR DIAGNOSIS OF DRUG ADDICTION
[patent_app_type] => utility
[patent_app_number] => 15/743836
[patent_app_country] => US
[patent_app_date] => 2016-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5248
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15743836
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/743836 | BIOMARKER FOR DIAGNOSIS OF DRUG ADDICTION AND KIT FOR DIAGNOSIS OF DRUG ADDICTION | Jul 11, 2016 | Abandoned |
Array
(
[id] => 15469045
[patent_doc_number] => 10550387
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Therapeutic agent for a lung disease and/or method for screening for the same
[patent_app_type] => utility
[patent_app_number] => 15/741224
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 13091
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741224
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/741224 | Therapeutic agent for a lung disease and/or method for screening for the same | Jun 29, 2016 | Issued |
Array
(
[id] => 11400386
[patent_doc_number] => 20170020925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'METHODS FOR MONITORING CELLULAR STATES AND FOR IMMORTALIZING MESENCHYMAL STEM CELL'
[patent_app_type] => utility
[patent_app_number] => 15/188794
[patent_app_country] => US
[patent_app_date] => 2016-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 41168
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15188794
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/188794 | METHODS FOR MONITORING CELLULAR STATES AND FOR IMMORTALIZING MESENCHYMAL STEM CELL | Jun 20, 2016 | Abandoned |
Array
(
[id] => 12904591
[patent_doc_number] => 20180193372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => NOVEL BIOMARKER FOR DIAGNOSING RESISTANCE TO ANTICANCER AGENT FOR BILLARY TRACT CANCER AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/735833
[patent_app_country] => US
[patent_app_date] => 2016-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15735833
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/735833 | NOVEL BIOMARKER FOR DIAGNOSING RESISTANCE TO ANTICANCER AGENT FOR BILLARY TRACT CANCER AND USE THEREOF | Jun 15, 2016 | Abandoned |
Array
(
[id] => 12490701
[patent_doc_number] => 09994847
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => miR-29 mimics and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/175636
[patent_app_country] => US
[patent_app_date] => 2016-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 41
[patent_no_of_words] => 15115
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15175636
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/175636 | miR-29 mimics and uses thereof | Jun 6, 2016 | Issued |
Array
(
[id] => 11542837
[patent_doc_number] => 20170096662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'ADMINISTERING ANTISENSE OLIGONUCLEOTIDES COMPLEMENTARY TO HUMAN APOLIPOPROTEIN B'
[patent_app_type] => utility
[patent_app_number] => 15/157678
[patent_app_country] => US
[patent_app_date] => 2016-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30436
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15157678
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/157678 | ADMINISTERING ANTISENSE OLIGONUCLEOTIDES COMPLEMENTARY TO HUMAN APOLIPOPROTEIN B | May 17, 2016 | Abandoned |
Array
(
[id] => 12808390
[patent_doc_number] => 20180161300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => CITRIN INHIBITORS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 15/571071
[patent_app_country] => US
[patent_app_date] => 2016-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15571071
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/571071 | CITRIN INHIBITORS FOR THE TREATMENT OF CANCER | May 9, 2016 | Abandoned |
Array
(
[id] => 11270803
[patent_doc_number] => 20160333351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'Bi-Functional Short-Hairpin RNA (Bi-shRNA) Specific for Single-Nucleotide KRAS Mutations'
[patent_app_type] => utility
[patent_app_number] => 15/141280
[patent_app_country] => US
[patent_app_date] => 2016-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16163
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15141280
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/141280 | Bi-Functional Short-Hairpin RNA (Bi-shRNA) Specific for Single-Nucleotide KRAS Mutations | Apr 27, 2016 | Abandoned |
Array
(
[id] => 11025430
[patent_doc_number] => 20160222384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'Compositions for Targeted Delivery of siRNA'
[patent_app_type] => utility
[patent_app_number] => 15/132695
[patent_app_country] => US
[patent_app_date] => 2016-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24464
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15132695
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/132695 | Compositions for targeted delivery of siRNA | Apr 18, 2016 | Issued |
Array
(
[id] => 11025430
[patent_doc_number] => 20160222384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'Compositions for Targeted Delivery of siRNA'
[patent_app_type] => utility
[patent_app_number] => 15/132695
[patent_app_country] => US
[patent_app_date] => 2016-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24464
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15132695
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/132695 | Compositions for targeted delivery of siRNA | Apr 18, 2016 | Issued |
Array
(
[id] => 15309513
[patent_doc_number] => 10519447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => Therapeutic UNA oligomers and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/563579
[patent_app_country] => US
[patent_app_date] => 2016-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11619
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563579
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/563579 | Therapeutic UNA oligomers and uses thereof | Mar 31, 2016 | Issued |
Array
(
[id] => 11979654
[patent_doc_number] => 20170283808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'MIR-520B SEQUENCE FOR INHIBITING CANCER GROWTH AND SPREAD AND MEDICINE THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 15/085528
[patent_app_country] => US
[patent_app_date] => 2016-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 2841
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15085528
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/085528 | MIR-520B SEQUENCE FOR INHIBITING CANCER GROWTH AND SPREAD AND MEDICINE THEREFOR | Mar 29, 2016 | Abandoned |
Array
(
[id] => 11092343
[patent_doc_number] => 20160289311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CANCER BY RATIONAL TARGETING OF PROTEIN TRANSLATION'
[patent_app_type] => utility
[patent_app_number] => 15/084459
[patent_app_country] => US
[patent_app_date] => 2016-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18220
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15084459
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/084459 | Compositions and methods for treating cancer by rational targeting of protein translation | Mar 28, 2016 | Issued |
Array
(
[id] => 10996418
[patent_doc_number] => 20160193364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING MITOCHONDRIAL PYRUVATE CARRIER ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/078872
[patent_app_country] => US
[patent_app_date] => 2016-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 44892
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15078872
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/078872 | COMPOSITIONS AND METHODS FOR MODULATING MITOCHONDRIAL PYRUVATE CARRIER ACTIVITY | Mar 22, 2016 | Abandoned |
Array
(
[id] => 12185735
[patent_doc_number] => 20180044672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'Pericyte Long Non-Coding RNAs'
[patent_app_type] => utility
[patent_app_number] => 15/554391
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 16053
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15554391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/554391 | Pericyte Long Non-Coding RNAs | Mar 17, 2016 | Abandoned |